Expecting SP to be punished until SMRA.
So reliant on SMRA it is really concerning. Plus, we are building production facilities that are not SMRA approved. So that means WHA actually needs to make sales and have a prepared market share to start functioning as an actual business (ie, operate for profit not cap raises).
Might be a long wait and another cap raise to get good results. Unless SMRA and those offtake partners achieve good sales on our behalf.
I wonder long term we are better suited to be an SM1 instead of a A2M or BAL.
- Forums
- ASX - By Stock
- WNX
- Ann: Financial Year 2018 - Summary
Ann: Financial Year 2018 - Summary, page-62
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WNX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $38.69M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $19.79K | 649.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 210736 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 332497 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 210736 | 0.030 |
1 | 348000 | 0.029 |
4 | 1223886 | 0.028 |
2 | 62053 | 0.027 |
4 | 733186 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 332497 | 1 |
0.032 | 1625000 | 3 |
0.033 | 1280000 | 2 |
0.034 | 500000 | 1 |
0.035 | 25538 | 3 |
Last trade - 13.55pm 15/07/2024 (20 minute delay) ? |
Featured News
WNX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online